Pirlindole

Pirlindole

SCHEMBL466384

CC(CCc1ccc2c(c1)OCO2)NN.Cc1ccc2c(c1)c1c3n2CCNC3CCC1

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 6/20 0.59
MEN1 O00255 5/20 0.59
KMT2A Q03164 5/20 0.59
KDM4E B2RXH2 4/20 0.59
CYP1A2 P05177 3/20 0.59
CYP2D6 P10635 3/20 0.59
TP53 P04637 3/20 0.59
CYP3A4 P08684 2/20 0.59
TEAD4 Q15561 2/20 0.59
HTR1A P08908 1/20 0.59
ADRA2A P08913 1/20 0.59
CHRM1 P11229 1/20 0.59
MAOA P21397 1/20 0.59
DRD1 P21728 1/20 0.59
SLC6A2 P23975 1/20 0.59
TEAD1 P28347 1/20 0.59
SLC6A4 P31645 1/20 0.59
SLC6A3 Q01959 1/20 0.59
KCNH2 Q12809 1/20 0.59
TEAD2 Q15562 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pirlindole SCHEMBL29500947 0.77 HSD17B10 (1.00) HSD17B10MEN1KMT2AKDM4ECYP1A2
Pirlindole SCHEMBL373564 0.77 HSD17B10 (1.00) HSD17B10MEN1KMT2AKDM4ECYP1A2
Pirlindole SCHEMBL18877133 0.77 HSD17B10 (1.00) HSD17B10MEN1KMT2AKDM4ECYP1A2
Pirlindole SCHEMBL18878061 0.77 HSD17B10 (1.00) HSD17B10MEN1KMT2AKDM4ECYP1A2
Pirlindole SCHEMBL4157397 0.76 HSD17B10 (0.97) HSD17B10MEN1KMT2AKDM4ECYP1A2
Pirlindole SCHEMBL30984462 0.73 HSD17B10 (1.00) HSD17B10MEN1KMT2AKDM4ECYP1A2
Pirlindole SCHEMBL3761340 0.73 HSD17B10 (1.00) HSD17B10MEN1KMT2AKDM4ECYP1A2
SCHEMBL4152460 0.72 HSD17B10 (1.00) HSD17B10MEN1KMT2AKDM4ECYP1A2
Safrazine SCHEMBL437129 0.71 TAAR1 (0.57) KDM4ECYP2D6SLC6A2SLC6A4SLC6A3
Safrazine SCHEMBL29359452 0.71 TAAR1 (0.57) KDM4ECYP2D6SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2405914-A1 COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND TREATMENT OF ADDICTIONS Omeros Corporation (US) 2012-01-18 EP disclosed
WO-2010105103-A1 COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND TREATMENT OF ADDICTIONS OMEROS CORPORATION (US) 2010-09-16 WO disclosed